If you have been reading about BDNF and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-01-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
Published research covers ischemic stroke, traumatic brain injury, cognitive impairment, optic nerve conditions and attention-related measures. Much of the human evidence comes from small trials conducted in one country, which limits how far the results generalize. Animal models supply the larger share of the data, and effects seen in rodents do not transfer automatically to people. Reviews have noted that methodological reporting is often incomplete, making it difficult to pool results or compare treatment schedules across studies.
Pharmacokinetic accounts emphasize rapid breakdown. After intravenous dosing the intact peptide disappears from blood within minutes, and nasal delivery produces low but measurable concentrations. Metabolites rather than the parent molecule may account for part of the observed activity, although the relative contribution is unresolved. Dosing in the literature varies widely and no optimal schedule has been agreed. These gaps are regularly cited as a reason the findings have not produced broad clinical adoption beyond the original research setting.
Common degradation pathways include oxidation of the methionine side chain, hydrolysis of the peptide backbone, and aggregation under unfavourable pH or concentration. Stability studies typically monitor the main peak by chromatography and report total related substances as a percentage. Because no official monograph exists, acceptance criteria vary between laboratories, and reported purity values are not directly comparable across suppliers. Analysts therefore document the method, column, and detection wavelength alongside each result, and open questions remain about how much biological activity the oxidised forms retain.
Solid semax is typically supplied as a lyophilised powder that is hygroscopic and sensitive to moisture, light, and repeated temperature cycling. Long-term storage of the dry peptide is generally recommended at approximately -20 degrees Celsius, while shorter working periods may use refrigeration at 2 to 8 degrees Celsius. Vials should remain tightly closed and desiccated when brought to room temperature, because condensation can damage the material before it is weighed. Dividing a batch into aliquots is preferable to thawing one container repeatedly.
| Property | Value | Notes |
|---|---|---|
| Primary research models | Rodent studies | Largest share of published data |
| Reported markers | BDNF and NGF expression | Measured mainly in animal tissue |
| Common administration | Intranasal | Matches the registered formulation |
| Blood residence time | Minutes | Rapid enzymatic degradation |
| Evidence quality | Small trials, limited replication | Noted repeatedly in reviews |
Practical handling follows from those properties. Bulk material is best divided into single-use portions soon after receipt, because each thaw exposes the whole container to moisture and temperature cycling. Vials should be allowed to reach room temperature before opening to prevent condensation on the powder. Low-binding plasticware reduces loss of dilute solutions, and sterile filtration is used when a preparation must remain free of microbial growth. Records of batch number, reconstitution date and storage history are what allow a later analytical result to be interpreted meaningfully.
Identity and purity of Semax are established mainly by reversed-phase high-performance liquid chromatography coupled with mass spectrometry. The chromatographic trace gives a purity estimate as a percentage of total peak area, while electrospray or matrix-assisted laser desorption ionization confirms the molecular mass against the calculated value. Amino acid analysis and sequence-specific fragmentation provide further confirmation when a supplier's chain of custody is unclear. Vendors frequently quote a purity figure without stating the detection wavelength or the integration method, which limits how far one number can be compared with another.
Quality documentation for research-grade peptide usually includes a certificate of analysis stating purity, identity, and residual counterion content. Batch-to-batch variation in purity and salt form is a recognized issue, and comparisons across suppliers require attention to the exact counterion, for example acetate versus trifluoroacetate. Sequence verification by tandem mass spectrometry provides stronger evidence than a single mass measurement. For any study reporting biological results, the analytical method and the measured purity should be stated explicitly. Independent verification of supplier claims is considered good practice.
Semax is supplied as a lyophilized powder that appears white to off-white. It dissolves readily in water, phosphate-buffered saline, and other aqueous media, which simplifies preparation of working solutions for laboratory use. The nasal products registered in Russia are dilute aqueous solutions, typically around 0.1 percent peptide by weight. Organic solvents are rarely necessary and can complicate handling. Because the peptide is hygroscopic, weighing should be performed quickly and with minimal exposure to ambient humidity.
Solid material is normally kept at minus 20 degrees Celsius in a sealed, desiccated container. Reconstituted solutions are less stable and are usually divided into single-use aliquots before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of activity. Light exposure is minimized by using amber glassware or foil wrapping. Published stability data for this peptide are sparse, so recommended storage conditions rest mainly on general practice for short synthetic peptides rather than on dedicated study.
Claims about enhanced focus, memory, or mood in healthy people rest mostly on anecdotal reports and community discussion rather than on controlled data. It remains unclear whether any cognitive benefit observed in patients recovering from brain injury would extend to uninjured users. Dose-response relationships, long-term safety, and interactions with other drugs are not well characterized in the peer-reviewed literature. Questions about optimal route of administration and treatment duration likewise remain open.
Semax binds to melanocortin receptors and is thought to influence neuronal survival and plasticity rather than to act through the adrenal axis. Laboratory work has shown increased expression of brain-derived neurotrophic factor and nerve growth factor in treated tissue. Changes in c-Fos, a marker of neuronal activation, have also been reported. Because the peptide is rapidly degraded by peptidases, its effects are generally attributed to downstream signaling cascades rather than to sustained receptor occupancy.
Published studies are dominated by animal models of stroke, ischemia, and cognitive impairment, with a smaller number of human trials conducted in Russia. Many of the human reports are small, single-center, and published in Russian-language journals, which limits independent scrutiny. Outcome measures vary between studies and often rely on clinician-rated scales rather than objective biomarkers. Systematic reviews have noted the methodological weaknesses and called for larger, preregistered trials before firm conclusions can be drawn.
The safety of pivekimab sunirine was evaluated in a pooled population of 116 participants who received the approved dose of pivekimab sunirine. This pooled safety population included the 84 participants with blastic plasmacytoid dendritic cell neoplasm as well as additional enrolled participants with other CD123-positive blood or bone marrow cancers treated at the approved dose.
It is now known that the underlying physiological correlation for the increase in EPSP size is a postsynaptic upregulation of AMPARs at the membrane, which is accomplished through the interactions of AMPARs with many cellular proteins. The simplest explanation for LTP is as follows (see the long-term potentiation article for a much more detailed account). Glutamate binds to postsynaptic AMPARs and another glutamate receptor, the NMDA receptor (NMDAR). Ligand binding causes the AMPARs to open, and Na+ flows into the postsynaptic cell, resulting in a depolarization. NMDARs, on the other hand, do not open directly because their pores are occluded at resting membrane potential by Mg2+ ions. NMDARs can open only when a depolarization from the AMPAR activation leads to repulsion of the Mg2+ cation out into the extracellular space, allowing the pore to pass current. Unlike AMPARs, however, NMDARs are permeable to both Na+ and Ca2+. The Ca2+ that enters the cell triggers the upregulation of AMPARs to the membrane, which results in a long-lasting increase in EPSP size underlying LTP. The calcium entry also phosphorylates CaMKII, which phosphorylates AMPARs, increasing their single-channel conductance.
Il-86 English page on Ilyushin website Il-86 page on The State Aviation Museum of Ukraine National aviation university Vladimir Karnozov (January 10, 2018). "The First Serial Wide-Body Aircraft IL-86 Turned 40 Wednesday". Russian aviation.
== Function == This gene encodes a protein that belongs to the microtubule-associated protein family. The proteins of this family are thought to be involved in microtubule assembly, which is an essential step in neurogenesis. The product of this gene is a precursor polypeptide that presumably undergoes proteolytic processing to generate the final MAP1B heavy chain and LC1 light chain. Gene knockout studies of the mouse microtubule-associated protein 1B gene suggested an important role in development and function of the nervous system. Two alternatively spliced transcript variants have been described.
== External links == Deltamethrin Technical Fact Sheet - National Pesticide Information Center Deltamethrin General Fact sheet - National Pesticide Information Center Pyrethrins and Pyrethroids Fact Sheet - National Pesticide Information Center Deltamethrin Pesticide Information Profile - Extension Toxicology Network Deltamethrin Development Exposure - FASEB Journal
Sources: en.wikipedia.org
Other investigational drugs using RNAi that are being developed by pharmaceutical companies such as Arrowhead Pharmaceuticals, Dicerna, Alnylam Pharmaceuticals, Amgen, and Sylentis. These medications cover a variety of targets via RNAi and diseases. Investigational RNAi therapeutics in development:
Selective estrogen receptor modulators (SERMs) are an important class of hormonal therapy agents which act as antagonists of the estrogen receptor and are used primarily for the treatment and chemoprevention of breast cancer. Some members of this family, such as tamoxifen, are actually partial agonists, which can actually increase estrogen receptor signalling in some tissues, such as the endometrium. Tamoxifen is currently first-line treatment for nearly all pre-menopausal women with hormone receptor-positive breast cancer. Raloxifene is another partial agonist SERM which does not seem to promote endometrial cancer, and is used primarily for chemoprevention of breast cancer in high-risk individuals, as well as to prevent osteoporosis. Toremifene and fulvestrant are SERMs with little or no agonist activity, and are used for treatment of metastatic breast cancer.
Rapid evolutionary divergence, along with the multiple and parallel loss of orthologs in some lineages, can give the false appearance of the emergence of a novel gene from scratch Generally speaking, expression of young, primate-specific genes is enriched in the fetal human brain relative to the expression of similarly young genes in the mouse brain. Most of these young genes, several of which originated de novo, are expressed in the neocortex, which is thought to be responsible for many aspects of human-specific cognition. Many of these young genes show signatures of positive selection, and functional annotations indicate that they are involved in diverse molecular processes, but are enriched for transcription factors. In addition to their roles in cancer processes, de novo originated human genes have been implicated in the maintenance of pluripotency and in immune function. The preferential expression of de novo genes in the testes is also suggestive of a role in reproduction. Given that the function of many de novo human genes remains uncharacterized, it seems likely that an appreciation of their contribution to human health and development will continue to grow.
=== Other characters === Lonnie Anderson (Josh C. Williams, Luke Edwards, Kristopher Kent Hill) – Crystal's eldest child, born to her deceased husband, Sonny. Art (Dan Butler) – A divorced accountant to whom Roseanne and Jackie sell a motorcycle, and who provides tax services to Lanford Custom Cycle. Bob (John McConnell) – A close friend of Dan's. Dwight (William Sadler) – A buddy of Dan's who appears in the early seasons of Roseanne, who had a crush on Jackie. In The Conners, there is another character named Dwight who Dan appears to be friends with, but the character is not portrayed by William Sadler and might be a different character altogether. Fisher (Matt Roth) – Jackie's former long-time boyfriend, whom Dan ultimately went to jail for assaulting after learning he abused Jackie. Stacey Flagler (Traci Lords) – A waitress at the Lunchbox. George (Joseph Gordon-Levitt) – D.J.'s classmate. Gary Hall (Brian Kerwin) – Jackie's former fiancé. Heather (Heather Matarazzo) – D.J.'s girlfriend. Jimmy Meltrigger (Stephen Dorff) – Becky's former boyfriend from high school. Chip Lang (Jared Rushton) – Becky's former boyfriend from high school. Marla (Morgan Fairchild) – Nancy's girlfriend. Anne-Marie Mitchell (Adilah Barnes) – Roseanne's childhood friend, who is married to one of Dan's poker buddies, Chuckie. She and Chuck have a son, Chuck Jr., who is the same age as Lonnie and Darlene. Chuckie Mitchell (James Pickens Jr.) – Anne-Marie's husband, who occasionally worked with Dan.
== Adverse events == The most common adverse events at the beginning of treatment are nausea and headache. More serious adverse events are peripheral neuropathy, which can occur in up to 33% of patients with advanced disease, oral ulcers, oesophageal ulcers and, rarely, pancreatitis.
Sources: en.wikipedia.org
In this process, uranium hexafluoride is repeatedly diffused through a silver-zinc membrane, and the different isotopes of uranium are separated by diffusion rate (since uranium-238 is heavier it diffuses slightly slower than uranium-235). The molecular laser isotope separation method employs a laser beam of precise energy to sever the bond between uranium-235 and fluorine. This leaves uranium-238 bonded to fluorine and allows uranium-235 metal to precipitate from the solution. An alternative laser method of enrichment is known as atomic vapor laser isotope separation (AVLIS) and employs visible tunable lasers such as dye lasers. Another method used is liquid thermal diffusion. The only significant deviation from the 235U to 238U ratio in any known natural samples occurs in Oklo, Gabon, where natural nuclear fission reactors consumed some of the 235U some two billion years ago when the ratio of 235U to 238U was more akin to that of low enriched uranium allowing regular ("light") water to act as a neutron moderator akin to the process in humanmade light water reactors. The existence of such natural fission reactors which had been theoretically predicted beforehand was proven as the slight deviation of 235U concentration from the expected values were discovered during uranium enrichment in France.
== Early life == Dorian Andrew Mientjez Yates was born in Solihull on 19 April 1962. He grew up on a farm in nearby Hurley. When he was 13, his father died of a heart attack, after which he moved with his mother and sister to Walmley. He later lived in the Landywood and Castle Vale areas of Birmingham during his early professional bodybuilding years.
Rainer Lisiewicz (1 July 2004 – 12 May 2009) Jörg Seydler (12 May 2009 – 29 November 2009) Uwe Trommer (29 November 2009 – 30 June 2010) – Caretaker Joachim Steffens (1 July 2010 – 7 June 2011) Mike Sadlo (7 June 2011 – 7 December 2011) Willi Kronhardt (3 January 2012 – 30 June 2012) Marco Rose (1 July 2012 – 30 June 2013) Carsten Hänsel (1 July 2013 – 23 September 2013) Heiko Scholz (8 October 2013 – 23 September 2018) Björn Joppe (27 September 2018 – 17 December 2018) Rainer Lisiewicz (18 December 2018 – 19 October 2019) Wolfgang Wolf (20 October 2019 – 30 June 2020) Almedin Civa (1 July 2020 – 19 February 2024) Tomislav Piplica (19 February 2024 – 30 June 2024) Jochen Seitz (1 July 2024 – 30 June 2026) Torsten Ziegner (since 1 July 2026 –)
== Biological activity == Prodigiosin received renewed attention for its wide range of biological activities, including activities as antimalarial, antifungal, immunosuppressant, and antibiotic agents. It is perhaps best known for its capacity to trigger apoptosis of malignant cancer cells. The exact mechanism of this inhibition is highly complex and not entirely elucidated, but could involve multiple processes, including phosphatase inhibition, copper mediated cleavage of double stranded DNA, or disrupting the pH gradient through transmembrane transport of H+ and Cl- ions. As a result, prodigiosin is a highly promising drug lead, and is currently in preclinical phase study for pancreatic cancer treatment. Prodigiosin has recently been found to have excellent activity against stationary phase Borrelia burgdorferi, the causative agent of Lyme disease. Prodigiosin has been also reported to exhibit antimicrobial activity against Gram-positive bacteria including methicillin resistant Staphylococcus aureus (MRSA), Staphylococcus aureus, Enterococcus faecalis, as well as Gram-negative Escherichia coli, Vibrio vulnificus, Salmonella enterica. Although the exact mechanism of action is not completely understood, recent molecular docking studies show that prodigiosin may interact with fatty acid biosynthetic enzyme in bacteria. Prodigiosin is also found to act as algaecide against harmful algal bloom.
Adorno shortly thereafter participated in a meeting with the Berlin Sozialistischer Deutscher Studentenbund (SDS) and discussed "Student Unrest" with Szondi on West German Radio. However, as 1968 progressed, Adorno became increasingly critical of the disruptions students experienced in university life. His isolation was only compounded by articles published in the magazine alternative, which, following the lead of Hannah Arendt's articles in Merkur, claimed Adorno had subjected Benjamin to pressure during his years of exile in Berlin and compiled Benjamin's Writings and Letters with a great deal of bias. In response, Benjamin's longtime friend Gershom Scholem, wrote to the editor of Merkur to express his disapproval of the "in part, shameful, not to say disgraceful" remarks by Arendt. Relations between students and the West German state continued to deteriorate. In spring 1968, a prominent SDS spokesman, Rudi Dutschke, was gunned down in the streets; in response, massive demonstrations took place, directed in particular against the Springer Press, which had led a campaign to vilify the students. An open appeal published in Die Zeit, signed by Adorno, called for an inquiry into the social reasons that gave rise to this assassination attempt as well as an investigation into the Springer Press' manipulation of public opinion. At the same time, however, Adorno protested against disruptions of his own lectures and refused to express his solidarity with their political goals, maintaining instead his autonomy as a theoretician.
Sources: en.wikipedia.org
The main proposal is modulation of neurotrophic factors such as brain-derived neurotrophic factor, supported largely by animal experiments. Receptor-level targets have not been firmly established. Most reviews describe the mechanism as only partially characterized.
The compound is registered as a medicine in Russia, so clinical work has concentrated there. Trials elsewhere are few and generally small. This geographic concentration is a recognized limitation in evidence reviews.
Some fraction may reach the central nervous system through olfactory pathways, and this is often cited as the rationale for the nasal route. The size of that fraction in humans is not well quantified. Blood concentrations after nasal dosing are low, which complicates measurement.
Dry powder is usually kept at about -20 degrees Celsius for long-term storage and at 2 to 8 degrees Celsius for short working periods. Containers should stay sealed and protected from light and moisture to limit degradation.